Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor

J Diabetes Investig. 2018 Sep;9(5):1224-1227. doi: 10.1111/jdi.12825. Epub 2018 Mar 25.

Abstract

A Japanese woman aged in her late 30s with severe insulin resistance and bodily features including a triangular face, prominent forehead, small chin, large and low-set ears, and ocular depression was investigated. A similar phenotype was not observed in other family members with the exception of her son, suggesting that the condition was caused by a de novo mutation that was transmitted from mother to son. Exome analysis showed the presence in the proband and her son of a c.1945C>T mutation in PIK3R1, a common mutation associated with SHORT (short stature, hyperextensibility of joints and/or inguinal hernia, ocular depression, Rieger anomaly, and teething delay) syndrome. Administration of a sodium-glucose cotransporter 2 inhibitor lowered the proband's hemoglobin A1c level and allowed a reduction in her insulin dose without treatment-related adverse events including ketoacidosis, exaggerated loss of body mass or hypoglycemia. Sodium-glucose cotransporter 2 inhibitors might thus offer an additional option for the treatment of genetic syndromes of severe insulin resistance.

Keywords: PIK3R1; Insulin resistance; Mutation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Class Ia Phosphatidylinositol 3-Kinase
  • Female
  • Humans
  • Insulin Resistance / genetics*
  • Mutation / genetics*
  • Pedigree
  • Phosphatidylinositol 3-Kinases / genetics*
  • Severity of Illness Index*
  • Sodium-Glucose Transporter 2 Inhibitors / pharmacology*
  • Syndrome
  • Treatment Outcome

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • PIK3R1 protein, human
  • Class Ia Phosphatidylinositol 3-Kinase